PCORCAB Stock Latest News
Private CompaniesOrca Bio Emphasizes Focus on High-Precision Cell Therapies for MDS5d agoORCAB
Private CompaniesOrca Bio Highlights Long-Term Survival Data for FDA-Approved Cell Therapy3w agoORCAB
Private CompaniesOrca Bio Highlights Market Need for High-Precision Cell Therapies in Blood Cancers1M agoORCAB
Private CompaniesOrca Bio Emphasizes Manufacturing Scale in Cell Therapy Strategy1M agoORCAB
Private CompaniesOrca Bio Emphasizes Leukemia Burden and Focus on High-Precision Cell Therapies1M agoORCAB
Private CompaniesPatient-Centric Focus Underscores Orca Bio’s Commitment to Blood Cancer Cell Therapies2M agoORCAB
Private CompaniesPatient-Centric Positioning Emphasized in Orca Bio Cancer Survivorship Messaging4M agoORCAB
Private CompaniesOrca Bio Emphasizes Cancer Survivorship and Patient Support Focus4M agoORCAB
Private CompaniesOrca Bio Reaffirms Commitment to Clinical Trials and Safety Foundations5M agoORCAB
Private CompaniesOrca Bio Emphasizes Role of Clinical Trials in Advancing Cell Therapy5M agoORCAB
Private CompaniesOrca Bio Highlights Role of Clinical Trials in Advancing Cell Therapy5M agoORCABPrivate CompaniesOrca Bio Highlights Foundational Role of Late Scientific Advisor in Cell Therapy Safety5M agoORCAB
Private CompaniesOrca Bio Reflects on Scientific Advisor’s Role in Foundational Safety Practices5M agoORCAB
Private CompaniesOrca Bio Reflects on Scientific Advisor’s Influence on Cell Therapy Practices5M agoORCAB
Private CompaniesOrca Bio Emphasizes High-Precision Cell Therapy Focus in Acute Myeloid Leukemia6M agoORCAB
Private CompaniesOrca Bio Emphasizes High-Precision Cell Therapy Focus in Acute Myeloid Leukemia6M agoORCAB


